A retrospective assessment of 809 patients operated on in 1990-1998 was performed. A patient-based outcome questionnaire also was incorporated into the study. The outcome was graded according to the Functional Economic Rating scale. A total of 64% of the patients were relieved of their complaints 3.2-10.2 years (median 6.3 years) after lumbar disc surgery. An excellent outcome, defined as Prolo scale of 9 or 10, was achieved in 55.8%, a good outcome (Prolo scale 7 or 8) in 20.7%, a fair outcome (Prolo scale 5 or 6) in 11.4%, and a poor outcome (Prolo scale of
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00024720-200304000-00006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Usefulness of Intraoperative Neurophysiological Monitoring in Intradural Spinal Tumor Surgeries.
J Clin Med
December 2024
Clinical Neurophysiology Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
Due to the absence of studies supporting the role of intraoperative neurophysiological monitoring (IONM) in intradural spinal tumors, this study evaluates the clinical outcome after these surgeries in relation to the use of the advanced intraoperative neurophysiological techniques. This is an observational, descriptive and retrospective study of two cohort groups in relation to the presence or absence of IONM during the intervention and the subsequent evaluation of the clinical and functional results in the short and medium terms. Ninety-six patients with extra- or intramedullary intradural spinal tumors operated on by the neurosurgery team of our center completed the current study.
View Article and Find Full Text PDFCan the 6-minute Walking Test Assess Ambulatory Function Impairment in Patients With Cervical Spondylotic Myelopathy?
Spine (Phila Pa 1976)
November 2024
Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, Shandong, P.R. China.
Study Design: Prospective cohort study.
Objective: Investigating the ability of a 6-minute walking test (6MWT) to assess functional status in patients with cervical spondylotic myelopathy (CSM).
Summary Of Background Data: The 6MWT provides an objective assessment of a patient's ability to walk.
The postoperative clinical effects of utilizing 3D printed (Ti6Al4V) interbody fusion cages in posterior lumbar fusion: A retrospective cohort study.
Medicine (Baltimore)
June 2024
Department of Spine Surgery, Tianjin Hospital, Tianjin, China.
Background: The research focused on the postoperative effect of using interbody fusion cage in lumbar posterior lamina decompression and interbody fusion with pedicle screw by comparing the postoperative effect of using 3D printing (Ti6Al4V) and PEEK material interbody fusion cage.
Methods: Ninety-one patients with lumbar degenerative diseases from the Department of Spine Surgery of Tianjin Hospital were included in the study cohort. They were divided into 3D group (n = 39) and PEEK group (n = 52) according to the use of interbody fusion cage.
Neurosurgical Outcomes Among Non-English Speakers: A Systematic Review and a Framework for Future Research.
World Neurosurg
May 2024
Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA; Division of Pediatric Neurosurgery, Lucile Packard Children's Hospital, Stanford, California, USA. Electronic address:
Objective: In 2019, 22% of adults in the United States reported speaking a language other than English at home, representing 52% growth since 2000. This diversity in languages - and resulting possible communication barriers - represents a potential challenge to effective care. In this manuscript, we summarize clinical outcomes and healthcare utilization patterns of adult and pediatric neurosurgical patients who are non-English primary language speakers (NEPLS).
View Article and Find Full Text PDFTumor inflammation-associated neurotoxicity.
Nat Med
April 2023
Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Cancer immunotherapies have unique toxicities. Establishment of grading scales and standardized grade-based treatment algorithms for toxicity syndromes can improve the safety of these treatments, as observed for cytokine release syndrome (CRS) and immune effector cell associated neurotoxicity syndrome (ICANS) in patients with B cell malignancies treated with chimeric antigen receptor (CAR) T cell therapy. We have observed a toxicity syndrome, distinct from CRS and ICANS, in patients treated with cell therapies for tumors in the central nervous system (CNS), which we term tumor inflammation-associated neurotoxicity (TIAN).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!